Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
58,762,797
-
Total 13F shares
-
12,105,226
-
Share change
-
+12,105,226
-
Total reported value
-
$316,421,451
-
Price per share
-
$26.55
-
Number of holders
-
38
-
Value change
-
+$316,421,146
-
Number of buys
-
38
Institutional Holders of Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX) as of Q3 2021
As of 30 Sep 2021,
Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,105,226 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, CITADEL ADVISORS LLC, BlackRock Inc., Rock Springs Capital Management LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, FMR LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.